Table 2.
Percentages of positive urine toxicologies collected during the third trimester of pregnancy
Urine toxicology positive for | Standard protocol
|
Clinical trial
|
χ2 Meth | p Meth | χ 2 Bup | p Bup | χ2 TR | p TR | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Meth (n=51) | Bup (n=26) | SP (n=77) | Meth (n=19) | Bup (n=18) | (CT n=37) | |||||||
Opioids | 36% | 19% | 30% | 37% | 28% | 32% | 0.007 | 0.932 | 0.416 | 0.706 | 0.056 | 0.812 |
Cocaine | 7% | 9% | 8% | 16% | 6% | 11% | 1.239 | 0.355 | 0.178 | 1.000 | 0.311 | 0.719 |
Benzodiazepines | 34% | 18% | 29% | 16% | 17% | 16% | 2.178 | 0.140 | 0.016 | 1.000 | 2.039 | 0.153 |
Any additional substance | 52% | 23% | 42% | 47% | 33% | 41% | 0.132 | 0.717 | 0.559 | 0.498 | 0.026 | 0.871 |
SP, standard protocol; CT, clinical trial; Meth, methadone; Bup, buprenorphine; TR, treatment approach. χ2-test results are separately presented for each medication group (methadone/buprenorphine) and for the treatment approaches (SP/CT).